Optimind Pharma Corp. (OMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 02/28
(Values in thousands)
| 02-2023 | 11-2022 | 08-2022 | 06-2022 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 552 | 788 | 1,143 | 2 |
| Receivables | 116 | 42 | 19 | 12 |
| TOTAL | $668 | $830 | $1,162 | $14 |
| Non-Current Assets | ||||
| PPE Net | 95 | 102 | 110 | N/A |
| Investments And Advances | 50 | 466 | 431 | N/A |
| Intangibles | 371 | 2,861 | 1,514 | N/A |
| Other Non-Current Assets | 171 | 0 | 0 | 0 |
| TOTAL | $687 | $3,428 | $2,054 | $0 |
| Total Assets | $1,354 | $4,258 | $3,216 | $14 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 504 | N/A | N/A | 165 |
| Accounts payable and accrued liabilities | 92 | 65 | 62 | 46 |
| TOTAL | $625 | $95 | $87 | $248 |
| Non-Current Liabilities | ||||
| Long Term Debt | N/A | 465 | 456 | N/A |
| TOTAL | $90 | $553 | $553 | $0 |
| Total Liabilities | $715 | $649 | $640 | $248 |
| Shareholders' Equity | ||||
| Common Shares | 4,025 | 6,034 | 4,684 | 22,253 |
| Retained earnings | -3,425 | -2,480 | -2,163 | -25,643 |
| TOTAL | $640 | $3,609 | $2,576 | $-234 |
| Total Liabilities And Equity | $1,354 | $4,258 | $3,216 | $14 |